Amifostine Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice Through Inhibition of the PI3K/Akt/mTOR Signaling Pathway

Investigators explored the potential therapeutic effects and molecular mechanisms of amifostine on bleomycin (BLM)-induced pulmonary fibrosis in mice. A mouse model of pulmonary fibrosis was established using BLM.